Legal Representation
Attorney
Paul C. Llewellyn
USPTO Deadlines
Application History
11 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Jan 7, 2025 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
| Nov 26, 2024 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Nov 26, 2024 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Nov 20, 2024 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| Oct 29, 2024 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Oct 19, 2024 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Sep 12, 2024 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Aug 12, 2024 | TCCA | I | TEAS CHANGE OF CORRESPONDENCE RECEIVED | Loading... |
| Aug 12, 2024 | CHAN | I | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | Loading... |
| Aug 12, 2024 | COAR | I | TEAS CHANGE OF OWNER ADDRESS RECEIVED | Loading... |
| Apr 5, 2024 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 001
Biological materials being viral vectors for scientific and industrial use and for use in the manufacture and development of pharmaceutical and biopharmaceutical preparations; biological preparations for scientific and industrial use; Carriers for biologically active compounds, namely, chemical and biological preparations for use in the delivery of biologically active compounds, for scientific and general industrial manufacturing use; Viruses, viral vectors and viral constructs being biological preparations for scientific and industrial use; Cells and biological membranes being a biological preparation for scientific and industrial use; Carriers for biologically active compounds, namely, chemical and biological preparations for use in the delivery of biologically active compounds for use in industry and the manufacture of gene therapy products, pharmaceuticals, biopharmaceuticals and vaccines; Chemical preparations for scientific and industrial use; Biological preparations for manufacture and development of gene therapy products, pharmaceuticals, biopharmaceuticals and vaccines; Cells and biological membranes being biological preparations for manufacture and development of gene therapy products, pharmaceuticals, biopharmaceuticals and vaccines; Viruses, viral vectors being vector viruses and viral constructs being biological preparations for manufacture and development of gene therapy products, pharmaceuticals, biopharmaceuticals and vaccines
Class 040
Treatment of materials in the nature of cells, viruses, and biological membranes to obtain carriers for gene therapy products, pharmaceuticals, biopharmaceuticals and vaccines; Treatment of materials, namely, the conversion of cells, viruses, and biological membranes into biochemical preparations; Custom manufacturing of biological substances, materials, and preparations; Custom manufacturing of cells, viruses, viral vectors, viral constructs and biological membranes; Manufacturing and processing for others of cells, viruses, viral vectors, viral constructs and biological membranes for third parties; Manufacturing and processing for others of gene therapy products, pharmaceuticals, biopharmaceuticals, biological preparations and vaccines; Processing of biological and generic material for others
Classification
International Classes
001
040